Study Conduct

Benchmark Research relocates sites, launches six urgent care centers

Saturday, June 6, 2015

Benchmark Research has announced that it is relocating its investigative site locations as part of the launch of six new urgent and family care centers. The U.S.-based site network said it has already begun construction in high traffic retail areas in Austin, Texas; New Orleans, La.; and Sacramento, Calif., with plans to open three more Benchmark Urgent & Family Care Centers in San Francisco and Fort Worth and San Angelo, Texas, in 2016.

[Read More]

Certara endows lectureship in precision dosing at University of Manchester

Thursday, June 4, 2015

Certara, a global biosimulation technology-enabled drug development consultancy, is endowing a new three-year, full-time position—the Certara lecturer in precision dosing—at the Manchester Pharmacy School, the University of Manchester, England. This lectureship is intended to advance teaching and research into individual dose optimization modeling, and to demonstrate its application to cancer, pediatric and biologic therapies.

[Read More]

Guardian Research Network, Molecular Health to expand trial access for cancer patients

Monday, June 1, 2015

The Guardian Research Network, a nationwide consortium of community health systems based in Spartanburg, S.C., and Molecular Health, a biomedical company headquartered in Heidelberg, Germany, have announced a collaboration designed to provide therapeutic clinical trial access and molecular diagnostic decision support to the majority of cancer patients living in U.S. communities.

[Read More]

CISCRP Medical Heroes Appreciation event returns to DIA to celebrate clinical trial volunteers

Wednesday, May 27, 2015

The Center for Information and Study on Clinical Research Participation (CISCRP), an independent nonprofit organization, has announced the upcoming Medical Heroes Appreciation Walk in Washington D.C. to honor the volunteers who give the gift of participation in clinical research and to raise awareness about the importance of clinical research in advancing public health.

[Read More]

Verified Clinical Trials, Integreview IRB create new expedited research subject authorization review process

Thursday, May 21, 2015

Verified Clinical Trials (VCT) and Integreview IRB have developed a preferred partnership to stop dual enrollment in clinical trials and reduce protocol deviations while promoting safety. Research sites, CROs and pharmaceutical sponsors will benefit from this alliance in an effort to stop dual enrollment in clinical trials and reduce significant protocol violations from occurring. 

[Read More]